14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:ARGS
Delisted

Argos Therapeutics Fund Price (Quote)

NASDAQ Stock Exchange
Open Broker Account
$0.0536
+0 (+0%)
At Close: Apr 15, 2020
Forecast Signals Historical Prices Predictions Profile

Range Low Price High Price Comment
30 days $0.0536 $0.0536 Wednesday, 15th Apr 2020 ARGS stock ended at $0.0536. During the day the stock fluctuated 0% from a day low at $0.0536 to a day high of $0.0536.
90 days $0.0536 $0.0536
52 weeks $0.0350 $0.0840

Historical Argos Therapeutics prices

Date Open High Low Close Volume
Apr 17, 2019 $0.0800 $0.0800 $0.0651 $0.0800 11 492
Apr 16, 2019 $0.0660 $0.0800 $0.0660 $0.0800 6 924
Apr 15, 2019 $0.0660 $0.0800 $0.0660 $0.0800 9 658
Apr 12, 2019 $0.0640 $0.0800 $0.0640 $0.0800 1 952
Apr 11, 2019 $0.0800 $0.0800 $0.0800 $0.0800 3 023
Apr 10, 2019 $0.0730 $0.0800 $0.0660 $0.0800 11 845
Apr 09, 2019 $0.0680 $0.0800 $0.0650 $0.0800 13 646
Apr 08, 2019 $0.0665 $0.0800 $0.0640 $0.0800 25 255
Apr 05, 2019 $0.0640 $0.0850 $0.0640 $0.0850 926
Apr 04, 2019 $0.0700 $0.0825 $0.0700 $0.0825 3 174
Apr 03, 2019 $0.0660 $0.0850 $0.0660 $0.0850 6 964
Apr 02, 2019 $0.0755 $0.0850 $0.0660 $0.0850 1 344
Apr 01, 2019 $0.0650 $0.0850 $0.0650 $0.0850 2 232
Mar 29, 2019 $0.0650 $0.0850 $0.0650 $0.0850 569
Mar 28, 2019 $0.0650 $0.0850 $0.0650 $0.0850 8 060
Mar 27, 2019 $0.0640 $0.0850 $0.0640 $0.0850 6 409
Mar 26, 2019 $0.0770 $0.0850 $0.0640 $0.0850 62 027
Mar 25, 2019 $0.0640 $0.0900 $0.0640 $0.0900 2 401
Mar 22, 2019 $0.0640 $0.0850 $0.0640 $0.0850 10 853
Mar 21, 2019 $0.0850 $0.0850 $0.0850 $0.0850 159
Mar 20, 2019 $0.0850 $0.0850 $0.0850 $0.0850 194
Mar 19, 2019 $0.0652 $0.0850 $0.0640 $0.0850 5 390
Mar 18, 2019 $0.0601 $0.0840 $0.0600 $0.0840 11 081
Mar 15, 2019 $0.0701 $0.0800 $0.0642 $0.0800 16 826
Mar 14, 2019 $0.0647 $0.0830 $0.0647 $0.0830 872
Click to get the best stock tips daily for free!

About Argos Therapeutics

Argos Therapeutics, Inc. focuses on the development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases in North America. The company develops immunotherapies based on Arcelis, its proprietary technology platform. Its development stage products include AGS-003, which is under Phase III clinical trials for the treatment of metastatic renal cell carcinoma and other cancers; and AGS-004, which ... ARGS Profile

Golden Star

Ticker Date Change Price
CVBF May 01 2.75% $16.75
FTSL May 01 0.282% $46.03
EQC Apr 30 0.694% $18.72
HRB Apr 30 0.635% $47.23
BSCQ Apr 30 0.576% $19.09
BSJP Apr 29 0.306% $22.91
LYG Apr 29 1.56% $2.56
ORA Apr 29 4.68% $64.48
DHT Apr 24 3.10% $11.28
LPLA Apr 19 3.12% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT